Skip to main content
AI Studio  add-on for Spider.
ascopubs.org · HTTP 200

Ascopubs Scraper

Spider read ascopubs.org in 174 ms without a browser and returned 256 lines of clean markdown.

Get your free API key
Free balance on signup No card. Failed requests cost $0.
Response ascopubs.org/index.md markdown · 256 lines
JournalYearVolumeIssuePageAmerican Society of Clinical Oncology Educational BookFull AccessHEAD AND NECK CANCER May 18, 2023### Current Treatment Strategies and Risk Stratification for Oral CarcinomaJournal of Clinical OncologyFull AccessASCO SPECIAL ARTICLES Apr 10, 2025### Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline UpdateFull AccessASCO SPECIAL ARTICLES Mar 19, 2025### Fertility Preservation in People With Cancer: ASCO Guideline UpdateOpen AccessORIGINAL REPORTS Oct 21, 2023### Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E TrialFull AccessASCO SPECIAL ARTICLES Sep 16, 2025### Postmastectomy Radiation Therapy: An ASTRO-ASCO-SSO Clinical Practice GuidelineOpen AccessORIGINAL REPORTS Oct 23, 2023### Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II TrialSPECIAL ARTICLES Aug 11, 2014### Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano ClassificationFull AccessASCO SPECIAL ARTICLES Nov 01, 2021### Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline UpdateOpen AccessRAPID COMMUNICATIONS Nov 04, 2019### Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 StudyOpen AccessORIGINAL REPORTS Feb 02, 2022### Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung CancerFull AccessASCO SPECIAL ARTICLES May 30, 2018### Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
Code · Fields · Cost · Run it keyless, no account

The same call, in code.

The capture above came back as markdown. These examples add a key, so you get browser rendering, proxies, and concurrency on ascopubs.org.

ascopubs-org-scraper.ts
import { SpiderBrowser } from "spider-browser";

const spider = new SpiderBrowser({
  apiKey: process.env.SPIDER_API_KEY!,
});

await spider.connect();
const page = spider.page!;
await page.goto("https://ascopubs.org");

// No selectors, no schema. Spider reads the page and names the fields.
const data = await page.scrape();

console.log(data);
await spider.close();
ready to run · spider-browser, no selectors

Ready for volume? Get an API key →

Fields you can pull.

Business NameAddressPhoneCategoryRatingWebsite

Spider names these from the page. The capture above came back as markdown; the same call with return_format: "json" returns them as keys.

What ascopubs.org costs to scrape.

The capture above cost $0.000209 to fetch. Pricing is $1 per GB of pre-transformation bandwidth plus $0.001 per CPU minute, so a page like this one lands at a fraction of a cent. Failed requests are billed at $0.

  • Free balance on signup
  • No card required to test
  • Balance never expires
See the full pricing →

Run it keyless, no account

curl -X POST https://api.spider.cloud/scrape -H "Content-Type: application/json" -d '{"url": "https://ascopubs.org/", "return_format": "markdown"}'

More Directories scrapers.

Start scraping ascopubs.org.

You already have the call. A key raises the rate limit and turns on browser rendering, proxies, and concurrency. Balance never expires, and top-ups go through secure checkout.